Found 14 matching trials
Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age PHASE2 This study will evaluate the safety and immunogenicity of GSK Biologicals' ...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Hepatitis B Vaccination in Infants PHASE4 In the UK, infants currently receive a 5-in-1 vaccine (Pediacel) at 2, 3 an...
Show More Location
St George's Vaccien Institute
Learn More & Join Trial
Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6-12wks of Age PHASE3 The purpose of the present study is to demonstrate that the changes in the ...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 8 Weeks of Age PHASE3 The purpose of this study is to assess the immunogenicity in terms of antib...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination PHASE3 This is a follow-up of the primary series vaccination schedule in Study A3L...
Show More Location
Multiple Locations
Learn More & Join Trial
Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 12wks of Age PHASE3 The purpose of this study is to assess the immunogenicity in terms of antib...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Study of DTaP-IPV-Hep B-PRP-T Vaccine Given With Prevenar™ and Rotarix™ in Healthy Latin American Infants PHASE3 The purpose of this study is to generate immunogenicity and safety data of ...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-025) PHASE3 This study will evaluate the safety and tolerability and immunogenicity of ...
Show More Location
Queensland Children s Hospital ( Site 0004)
Learn More & Join Trial
Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and Infants PHASE1 This study is the first study of Sanofi's Pentavalent Meningococcal ABCYW v...
Show More Status
Active Not Recruiting
Location
Hospital das Clínicas da Universidade Federal de Minas Gerais- Site Number : 0760001
Learn More & Join Trial
Prophylactic Antipyretic Treatment in Children Receiving Pneumococcal Conjugate and Standard Infant Vaccines PHASE3 The purpose of this trial is to assess if the rate of febrile reactions fol...
Show More Location
GSK Investigational Site
Learn More & Join Trial